lundi 30 décembre 2019

Individualized pelvic physical therapy decreases incontinence, pain in post-prostatectomy patients

For decades, therapy to strengthen pelvic muscles has been the standard treatment for men dealing with urinary incontinence after prostate surgery. But a new study from UT Southwestern's Departments of Urology and Physical Medicine and Rehabilitation suggests that may not be the best approach. Individualized pelvic physical therapy decreases incontinence, pain in post-prostatectomy patients

lundi 23 décembre 2019

National veteran dataset will help dissect the relationship between mental illness and prostate cancer

There appears to be an unhealthy synergy between mental illness and prostate cancer, and researchers are working to dissect the relationship by first assembling the largest dataset ever of veterans with either condition or both. National veteran dataset will help dissect the relationship between mental illness and prostate cancer

samedi 21 décembre 2019

Patients' health values can impact success of treatment for pelvic floor problems

Researchers and health professionals in Swansea have revealed the value women put on their own health can have a direct effect on the success of medical treatment for pelvic floor problems. Patients' health values can impact success of treatment for pelvic floor problems

jeudi 19 décembre 2019

FDA approves new drug to treat adults with advanced urothelial or bladder cancer

The U.S. Food & Drug Administration granted accelerated approval to the drug enfortumab vedotin (EV) to treat adult patients with advanced urothelial or bladder cancer. FDA approves new drug to treat adults with advanced urothelial or bladder cancer

mercredi 11 décembre 2019

NCCN Patient Advocacy Summit closes gaps in perspective of value in cancer care

The National Comprehensive Cancer Network (NCCN) hosted an annual NCCN Patient Advocacy Summit: Delivering Value for Patients across the Oncology Ecosystem in Washington, DC, today. NCCN Patient Advocacy Summit closes gaps in perspective of value in cancer care

lundi 2 décembre 2019

MRI-guided ultrasound ablation: safer better treatment for prostate cancer

Prostate cancer may soon be treated more effectively using ultrasound at therapeutic levels, without the significant and distressing side effects of more traditional treatments. A new study presented on December 2, 2019, presents the outcome of using focused ultrasound ablation under MRI guidance in a novel procedure that can be used to treat both benign and malignant enlargement of the prostate gland. MRI-guided ultrasound ablation: safer better treatment for prostate cancer